Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD63 | CTRPv2 | pan-cancer | AAC | -0.28 | 2e-12 |
mRNA | BCL2L1 | CTRPv2 | pan-cancer | AAC | -0.24 | 7e-12 |
mRNA | PRPF38A | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
mRNA | ORC1 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
mRNA | SRSF3 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
mRNA | GRAMD3 | CTRPv2 | pan-cancer | AAC | -0.23 | 4e-11 |
mRNA | CNOT9 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-11 |
mRNA | TAF5 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-11 |
mRNA | ATP6V0E1 | CTRPv2 | pan-cancer | AAC | -0.24 | 7e-11 |
mRNA | GMEB1 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-11 |